cancer

New cancer diagnoses did not rebound as expected following pandemic

Cancer incidence trends in 2021 largely returned to what they were before the COVID-19 pandemic, according to a study by…

2 years ago

Clinical trial successfully repurposes cancer drug for hereditary bleeding disorder

A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the…

2 years ago

Study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

West African genetic ancestry was associated with increased prostate cancer among men living in disadvantaged neighborhoods but not among men…

2 years ago

Antibody-drug conjugate found effective against brain metastases in patients with HER2-positive breast cancer

A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those…

2 years ago

Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with…

2 years ago

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma…

2 years ago

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment

The recent U.S. Food and Drug Administration approval of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for advanced melanoma,…

2 years ago

Cancer survivors are at increased risk of disease throughout life

Swedish researchers have surveyed all people under the age of 25 who have had cancer since 1958. The study, led…

2 years ago

Fasting primes the immune system’s natural killer cells to better fight cancer, new study in mice finds

Periods of fasting reprogram the immune system's natural killer cells to better fight cancer, according to a new study in…

2 years ago

Proton therapy demonstrates advantages in Phase III head and neck cancer trial

According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson…

2 years ago